Form 4: Havencrest Healthcare Partners Distributes Oncology Institute Shares to Limited Partners

Sentiment:

SEC Form 4 Filing


Havencrest Healthcare Partners, L.P. distributed shares of Oncology Institute, Inc. common stock to its members and limited partners in a pro-rata in-kind distribution.

Summary

  • On August 16, 2024, TOI HC I, LLC distributed 8,701,823 shares of Oncology Institute, Inc. (TOI) common stock to its members.
  • Following this distribution, Havencrest Healthcare Partners GP, LLC held 7,631,418 shares, and TOI HC I, LLC held 100,000 shares.
  • Subsequently, Havencrest Healthcare Partners, L.P. distributed 7,631,418 shares to its limited partners.
  • After the second distribution, Havencrest Healthcare Partners GP, LLC held 152,626 shares, and TOI HC I, LLC held 100,000 shares.
  • The distributions were made in accordance with the governing documents of TOI HC I, LLC and Havencrest Healthcare Partners, L.P.

Sentiment

Score: 6

Explanation: The document is a standard SEC filing related to share distribution, indicating a neutral sentiment. It reflects routine portfolio management activities.

Industry Context

This filing indicates a restructuring of ownership within Havencrest Healthcare Partners regarding its holdings in Oncology Institute, Inc., which is common for private equity firms managing their investments.

Stakeholder Impact

  • The distribution of shares may impact the trading volume and price of Oncology Institute, Inc. stock.
  • Limited partners of Havencrest Healthcare Partners, L.P. now directly hold shares of Oncology Institute, Inc.

Key Dates

DateDescription
08/16/2024TOI HC I, LLC distributed shares of TOI common stock to its members and Havencrest Healthcare Partners, L.P. distributed shares to its limited partners.
08/20/2024Date of signatures for the SEC Form 4 filings.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.